|  | Immunotherapy | Control | P |
---|---|---|---|---|
Hypothyroidism | n | 24 | 12 | Â |
TSH (mIU/L) (median (range)) | 5.185 (0.853–48.800) | 6.345 (0.608–8.120) | 0.341 | |
FT4 (pmol/L) (median (range)) | 15.040 (1.230–9.640) | 10.860 (9.680–15.620) | 0.292 | |
onset (days) (median (range)) | 107 (49–137) | 139 (100–159) | < 0.001 | |
Hyperthyroidism | n | 18 | 39 | Â |
TSH (mIU/L) (median (range)) | 0.053 (0.018–0.237) | 0.069 (0.010–0.465) | 0.394 | |
FT4 (pmol/L) (median (range)) | 21 (11.500–20.820) | 18.27 (13.810–41.100) | 0.624 | |
onset (days) (median (range)) | 104 (60–148) | 112 (27–169) | 0.847 |